FDA Bans Peptides

Sam Ridgeway discusses the benefits of the healing peptide BPC-157, which he and his wife have used to aid recovery from injuries and surgeries, often surprising medical professionals with the rapid healing. However, the FDA has banned many peptides, including BPC-157, citing potential side effects and concerns about sanitary compounding conditions. Sam questions the FDA's logic given their existing oversight of compounding pharmacies and points out inconsistencies in their decision-making, particularly concerning another peptide, Thymus and Alpha 1, which showed promise in treating COVID. He critiques the FDA's alignment with Big Pharma's profitability rather than patient health, suggesting that these bans will push people towards unregulated black-market solutions. While Sam acknowledges the risks of seeking banned substances, he warns against clinics that offer these products, emphasizing the legal consequences and potential compromise on other health fronts.